Key result
Both mild prolonged and deep transient hypoglycemia induced marked changes in platelet-related proteins that persisted up to 24 hours in both type 2 diabetes patients and controls.
Why the study?
Severe hypoglycemia is associated with increased cardiovascular death risk and platelet responses have been described, but the impact of deep transient hypoglycemia versus prolonged milder hypoglycemia on platelet response remains unclear.
Does deep transient hypoglycemia compared to mild prolonged hypoglycemia affect platelet-derived protein responses in patients with type 2 diabetes and healthy controls?
Case-Control (n=63)
No
Does deep transient hypoglycemia compared to mild prolonged hypoglycemia affect platelet-derived protein responses in patients with type 2 diabetes and healthy controls?
Both mild prolonged and deep transient hypoglycemia induce significant and persistent changes in prothrombotic and inflammatory platelet-related proteins, potentially contributing to increased cardiovascular risk in patients with type 2 diabetes.
Answers are grounded in this paper and cite their sources.
Hypoglycemia may heighten thrombotic risk via platelet changes in T2D; hypothesis-generating and requires prospective validation.
OBJECTIVE: Severe hypoglycemia is associated with increased cardiovascular death risk, and platelet responses to hypoglycemia (hypo) have been described. However, the impact of deep transient hypo (deep-hypo) versus prolonged milder hypo (mild-hypo) on platelet response is unclear. RESEARCH DESIGN AND METHODS: Two hypo studies were compared; firstly, mild-hypo in 18-subjects (10 type-2-diabetes (T2D), 8 controls), blood glucose to 2.8mmoL/L (50 mg/dL) for 1-hour; secondly deep-hypo in 46-subjects (23 T2D, 23 controls), blood glucose to < 2.2mmoL/L (< 40 mg/dL) transiently. Platelet-related protein (PRP) responses from baseline to after 1-hour of hypo (mild-hypo) or at deep-hypo were compared, and at 24-hours post-hypo. Slow Off-rate Modified Aptamer (SOMA)-scan plasma protein measurement was used to determine PRP changes for 13 PRPs. RESULTS: In controls, from baseline to hypo, differences were seen for four PRPs, three showing increased %change in deep-hypo (Plasminogen activator inhibitor-1(PAI-1), CD40 ligand (CD40LG) and Protein-S), one showing increased %change in mild-hypo (von Willebrand factor (vWF)); at 24-hours in controls, %change for Protein-S remained increased in deep-hypo, whilst % change for vWF and plasminogen were increased in mild-hypo. In T2D, from baseline to hypo, differences were seen for 4 PRPs, three showing increased %change in deep-hypo (PAI-1, platelet glycoprotein VI and Tissue factor), one showing increased %change in mild-hypo (CD40LG); at 24-hours in T2D, %change for CD40LG remained increased, together with vWF, in deep-hypo. CONCLUSION: Both mild-hypo and deep-hypo showed marked PRP changes that continued up to 24-hours, showing that both the severity and duration of hypoglycemia are likely important and that any degree of hypoglycemia may be detrimental for increased cardiovascular risk events through PRP changes.
No takes yet. Share an insight, caveat, or question.
Moin et al. (2022) conducted a case-control in Type 2 diabetes (n=63). Induced hypoglycemia (deep transient vs mild prolonged) vs. Baseline and between-group comparisons was evaluated on Percent change in platelet-related proteins (PRPs) from baseline to hypoglycemia and 24 hours post-hypoglycemia. Both mild prolonged and deep transient hypoglycemia induced marked changes in platelet-related proteins that persisted up to 24 hours in both type 2 diabetes patients and controls.
Synapse has enriched 10 related papers. Consider them for comparative context: